Doctor profile · Federal record
Dr. Tiffany Autry, DNP FNP Mep-C
Dermatology Physician (CMS: Nurse Practitioner) · Las Cruces, NM
- NPI 1003389875
- Accepts Medicare
- MIPS 94.2 / 100 · 2023
- 8 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1005 S Telshor Blvd Ste A
Las Cruces, NM 880114879
(575) 262-7546
fax (575) 888-2273 - Mailing address
-
Po Box 871
Las Cruces, NM 880040871
Credentials & registration
- NPI registered
- January 2019 — 7 yrs on file
- Profile last updated
- December 30, 2024
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New Mexico #54435
- Medicaid
- NM #31106285
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1003389875. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,644
Distinct HCPCS
10
Medicare allowed
$84,611
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 495 | 102 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 367 | 234 | $73 | |
17000 |
Destruction of precancer skin growth, 1 growth | 241 | 158 | $49 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 139 | 139 | $91 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 118 | 90 | $45 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 84 | 50 | $103 | |
17110 |
Destruction of skin growth, 1-14 growths | 69 | 53 | $88 | |
11102 |
Biopsy of related skin growth, first growth | 58 | 55 | $78 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 47 | 47 | $58 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 26 | 26 | $136 |
In context: peer comparison
Among 3 peers in Las Cruces Dermatology Physician, average services per provider: 382. This provider delivers 4.3× the peer median.Open Payments
Industry payments received
All-time total
$1,073
Transactions
40
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 12 | $404.62 | |
| Revance Therapeutics, INC. | 2 | $208.65 | |
| Lilly USA, LLC | 14 | $202.93 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $66.74 | |
| Abbvie INC. | 3 | $45.03 | |
| Ucb, INC. | 1 | $38.02 | |
| Novartis Pharmaceuticals Corporation | 1 | $34.60 | |
| Organogenesis INC. | 1 | $21.99 | |
| Regeneron Healthcare Solutions, INC. | 1 | $21.12 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $16.41 | |
| Sun Pharmaceutical Industries INC. | 1 | $13.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
523
Patients
281
Total drug cost
$22,805
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 133 | 87 | $1,029 |
| Ketoconazole | Generic | 91 | 40 | $2,657 |
| Mupirocin | Generic | 50 | 47 | $480 |
| Clobetasol Propionate | Generic | 47 | 31 | $3,782 |
| Metronidazole | Generic | 34 | 16 | $2,762 |
| Doxycycline Hyclate | Generic | 27 | 14 | $699 |
| Fluorouracil | Generic | 26 | 15 | $2,279 |
| Fluocinolone Acetonide (Fluocinolone/Shower CAP) | Brand | 22 | 16 | $2,270 |
| Tretinoin | Generic | 18 | 0 | $2,089 |
| Betamethasone Valerate | Generic | 17 | 0 | $485 |
Frequently asked questions
What is Dr. Tiffany Autry's medical specialty?
Dr. Tiffany Autry practices Dermatology Physician in Las Cruces, NM.
Where does Dr. Tiffany Autry practice?
Dr. Tiffany Autry practices at 1005 S Telshor Blvd Ste A, Las Cruces, NM 880114879. Office phone: 5752627546.
What is Dr. Tiffany Autry's NPI?
Dr. Tiffany Autry's National Provider Identifier (NPI) is 1003389875, issued by NPPES.
Does Dr. Tiffany Autry accept Medicare assignment?
Yes. Dr. Tiffany Autry accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tiffany Autry commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.